» Articles » PMID: 25825213

A Novel, Nonanaphylactogenic, Bispecific IgE-CD3 Antibody Eliminates IgE(+) B Cells

Overview
Date 2015 Apr 1
PMID 25825213
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

Development of a Cytotoxic Antibody-Drug Conjugate Targeting Membrane Immunoglobulin E-Positive Cells.

Rodak A, Stadlbauer K, Bobbili M, Smrzka O, Ruker F, Wozniak Knopp G Int J Mol Sci. 2023; 24(19).

PMID: 37834445 PMC: 10573690. DOI: 10.3390/ijms241914997.


Bispecific T-Cell Engagers Targeting Membrane-Bound IgE.

Rodak A, Stadlmayr G, Stadlbauer K, Lichtscheidl D, Bobbili M, Ruker F Biomedicines. 2021; 9(11).

PMID: 34829798 PMC: 8615095. DOI: 10.3390/biomedicines9111568.


Tuning IgE: IgE-Associating Molecules and Their Effects on IgE-Dependent Mast Cell Reactions.

Ando T, Kitaura J Cells. 2021; 10(7).

PMID: 34359869 PMC: 8305778. DOI: 10.3390/cells10071697.


Tracing IgE-Producing Cells in Allergic Patients.

Eckl-Dorna J, Villazala-Merino S, Campion N, Byazrova M, Filatov A, Kudlay D Cells. 2019; 8(9).

PMID: 31466324 PMC: 6769703. DOI: 10.3390/cells8090994.


Anti-IgE therapy for IgE-mediated allergic diseases: from neutralizing IgE antibodies to eliminating IgE B cells.

Hu J, Chen J, Ye L, Cai Z, Sun J, Ji K Clin Transl Allergy. 2018; 8:27.

PMID: 30026908 PMC: 6050685. DOI: 10.1186/s13601-018-0213-z.